Results 131 to 140 of about 46,918 (224)

System Xc-pathway as a potential regulatory target in neurological disorders. [PDF]

Front Pharmacol
Chen Y, Xiao W, Qian C, Huang L, Lv J, Wang Z, Luo Y.   +6 more
europepmc   +1 more source

Interplay Among Synaptic Glutamate Release and Excitotoxicity: Neuronal Damage and Graphene-Based Materials Related Protection. [PDF]

Life (Basel)
Cellot G, Ballerini L.
europepmc   +1 more source

Anesthetic Neuroprotection Based on Ion-Channel-Modulating Drugs in Acute Traumatic Brain Injury. [PDF]

Cureus
Zamora EL, Alvarez Ramirez D, Soto Cordero CA, Chavarría R, Montoya S.   +4 more
europepmc   +1 more source

Intermediate filaments link glutamate-aspartate transporter deficiency to cochlear synaptopathy. [PDF]

FEBS J
Krumpoeck PE, Landegger LD.
europepmc   +1 more source

Dynamic management of traumatic brain injury in rat: injectable hydrogels and future directions. [PDF]

Front Neurol
Jiang H, Luo X, Li H, Guo Z, Cao Y, Yang L, Wu H, Li P.   +7 more
europepmc   +1 more source

Apelin-13 confers Neuropeptide Y-mediated neuroprotection and preserves learning and allocentric memory in D-glutamic acid-induced excitotoxicity in rats. [PDF]

Mol Neurobiol
Oruc KY, Oruc A, Arslan R, Diriarin FP, Mengi M, Tanriverdi G, Yanar K, Ozeren Eser M, Agturk G, Sonkurt AI, Guler B, Seymen HO.   +11 more
europepmc   +1 more source

Letter to the editor regarding "Inhibition of Mettl3-mediated m6A RNA modification of HMGCS1 protects retinal ganglion cells from glutamate excitotoxicity-induced ferroptosis in a rat model of glaucoma." [PDF]

Int J Surg
Ye L, Hu X.
europepmc   +1 more source

Nanomaterial-Based Drug Delivery Systems for Ischemic Stroke: From Blood-Brain Barrier Crossing to Neuroprotection. [PDF]

Int J Nanomedicine
He Y, Qu M, Yu L, Lu Y, Hong J, Sun M, Yang H, Mi W, Guo H, Ma Y.   +9 more
europepmc   +1 more source